These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16284351)

  • 1. Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide.
    Metzler C; Arlt AC; Gross WL; Brandt J
    Ann Rheum Dis; 2005 Dec; 64(12):1798-800. PubMed ID: 16284351
    [No Abstract]   [Full Text] [Related]  

  • 2. Leflunomide-induced peripheral neuropathy.
    Kho LK; Kermode AG
    J Clin Neurosci; 2007 Feb; 14(2):179-81. PubMed ID: 17107800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathy associated with leflunomide: a case series.
    Martin K; Bentaberry F; Dumoulin C; Longy-Boursier M; Lifermann F; Haramburu F; Dehais J; Schaeverbeke T; Bégaud B; Moore N
    Ann Rheum Dis; 2005 Apr; 64(4):649-50. PubMed ID: 15769926
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral neuropathy in patients on leflunomide.
    Bharadwaj A; Haroon N
    Rheumatology (Oxford); 2004 Jul; 43(7):934. PubMed ID: 15213340
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral neuropathy associated with leflunomide: is there a risk patient profile?
    Martin K; Bentaberry F; Dumoulin C; Miremont-Salamé G; Haramburu F; Dehais J; Schaeverbeke T
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):74-8. PubMed ID: 16845649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy in patients treated with leflunomide.
    Bonnel RA; Graham DJ
    Clin Pharmacol Ther; 2004 Jun; 75(6):580-5. PubMed ID: 15179412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral neuropathy and leflunomide].
    Santiago T; Rovisco J; Silva J; Malcata A
    Acta Reumatol Port; 2011; 36(3):313-4. PubMed ID: 22113609
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.
    Østensen M; von Esebeck M; Villiger PM
    J Rheumatol; 2007 Jun; 34(6):1266-9. PubMed ID: 17516615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
    Ju JH; Kim SI; Lee JH; Lee SI; Yoo WH; Choe JY; Chung SH; Lee J; Lee YH; Lee SS; Yoon HJ; Yoon CH; Kim HY; Park SH
    Arthritis Rheum; 2007 Jun; 56(6):2094-6. PubMed ID: 17530652
    [No Abstract]   [Full Text] [Related]  

  • 10. Cavitating pneumonia, a severe complication of leflunomide therapy in chronic polyarthritis.
    Bruyn GA; Jansen TL; Ten Brinke A; De Vries M; Houtman PM; van Roon EN
    Rheumatology (Oxford); 2007 Mar; 46(3):553-4. PubMed ID: 17132691
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerability of methotrexate and leflunomide combination therapy for inflammatory arthritis in routine clinical practice: results of a four-centre study.
    Kaul A; O'Reilly DT; Slack RK; Collins D; Walmsley J; Duke O; Kiely PD
    Rheumatology (Oxford); 2008 Sep; 47(9):1430-1. PubMed ID: 18628287
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide.
    Martinez-Taboada VM; Rodriguez-Valverde V; Gonzalez-Vilchez F; Armijo JA
    Rheumatology (Oxford); 2004 Nov; 43(11):1451-3. PubMed ID: 15501999
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy outcome in women exposed to leflunomide before or during pregnancy.
    Cassina M; Johnson DL; Robinson LK; Braddock SR; Xu R; Jimenez JL; Mirrasoul N; Salas E; Luo YJ; Jones KL; Chambers CD;
    Arthritis Rheum; 2012 Jul; 64(7):2085-94. PubMed ID: 22307734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal pneumonitis under leflunomide therapy.
    Vallbracht II; Popper HH; Rieber J; Nowak F; Gallenberger S; Piper B; Helmke K
    Rheumatology (Oxford); 2005 Dec; 44(12):1580-1. PubMed ID: 16118229
    [No Abstract]   [Full Text] [Related]  

  • 15. Interstitial lung diseases after leflunomide use in nephropathy: an analysis of reported cases in Chinese literature.
    Zhang WX; Zhou W; Zhang ZQ; Zhao XW
    Nephrol Dial Transplant; 2011 Apr; 26(4):1416-20. PubMed ID: 21193642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide (Arava)-induced cystoid macular oedema.
    Barak A; Morse LS; Schwab I
    Rheumatology (Oxford); 2004 Feb; 43(2):246-8. PubMed ID: 14739469
    [No Abstract]   [Full Text] [Related]  

  • 17. Leflunomide-induced subacute cutaneous lupus erythematosus.
    Goëb V; Berthelot JM; Joly P; Mejjad O; de Quatrebarbes J; Reynaud-Hautin C; Vittecoq O; Le Loët X
    Rheumatology (Oxford); 2005 Jun; 44(6):823-4. PubMed ID: 15757964
    [No Abstract]   [Full Text] [Related]  

  • 18. [Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].
    Glück T; Müller-Ladner U
    Dtsch Med Wochenschr; 2007 Sep; 132(37):1901-4. PubMed ID: 17823884
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurological complications of infliximab.
    Tektonidou MG
    J Rheumatol; 2007 Jan; 34(1):237; author reply 237-8. PubMed ID: 17216701
    [No Abstract]   [Full Text] [Related]  

  • 20. Leflunomide-associated infections in rheumatoid arthritis.
    Jenks KA; Stamp LK; O'Donnell JL; Savage RL; Chapman PT
    J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.